Compare Stocks: CVS, DB, LEA, MS, and POST

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$89.43 +0.5%	$89.96	$69.51 ▼ $110.68	$113.89B	0.58	11.01 million shs	11.08 million shs
DB Deutsche Bank	$37.32 +0.6%	$35.78	$28.12 ▼ $41.62	$71.97B	1.05	2.91 million shs	1.51 million shs
LEA Lear	$109.71 +0.1%	$120.50	$99.00 ▼ $150.33	$5.28B	1.28	564,283 shs	559,851 shs
MS Morgan Stanley	$190.59 +1.6%	$193.73	$152.80 ▼ $232.25	$293.16B	1.23	6.91 million shs	5.27 million shs
POST Post	$80.77 -1.3%	$78.62	$71.45 ▼ $117.28	$3.71B	0.42	705,251 shs	829,477 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	+0.45%	+11.93%	+1.71%	-5.79%	+12.16%
DB Deutsche Bank	+0.69%	+1.72%	+10.81%	-2.81%	-1.09%
LEA Lear	+0.16%	-7.49%	-6.47%	-10.43%	+0.30%
MS Morgan Stanley	+1.63%	-1.76%	+0.34%	-12.81%	+14.53%
POST Post	-1.20%	-4.84%	+5.27%	+0.26%	-23.73%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$89.43 +0.5%	$89.96	$69.51 ▼ $110.68	$113.89B	0.58	11.01 million shs	11.08 million shs
DB Deutsche Bank	$37.32 +0.6%	$35.78	$28.12 ▼ $41.62	$71.97B	1.05	2.91 million shs	1.51 million shs
LEA Lear	$109.71 +0.1%	$120.50	$99.00 ▼ $150.33	$5.28B	1.28	564,283 shs	559,851 shs
MS Morgan Stanley	$190.59 +1.6%	$193.73	$152.80 ▼ $232.25	$293.16B	1.23	6.91 million shs	5.27 million shs
POST Post	$80.77 -1.3%	$78.62	$71.45 ▼ $117.28	$3.71B	0.42	705,251 shs	829,477 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	+0.45%	+11.93%	+1.71%	-5.79%	+12.16%
DB Deutsche Bank	+0.69%	+1.72%	+10.81%	-2.81%	-1.09%
LEA Lear	+0.16%	-7.49%	-6.47%	-10.43%	+0.30%
MS Morgan Stanley	+1.63%	-1.76%	+0.34%	-12.81%	+14.53%
POST Post	-1.20%	-4.84%	+5.27%	+0.26%	-23.73%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVS CVS Health	2.92	Moderate Buy	$108.25	21.04% Upside
DB Deutsche Bank	2.69	Moderate Buy	$43.00	15.24% Upside
LEA Lear	2.31	Hold	$143.25	30.58% Upside
MS Morgan Stanley	2.52	Moderate Buy	$214.81	12.71% Upside
POST Post	2.33	Hold	$103.43	28.05% Upside

Current Analyst Ratings Breakdown

Latest CVS, DB, LEA, MS, and POST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/9/2026	CVS CVS Health	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C+) ➝ Buy (B-)
11/9/2026	LEA Lear	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C+) ➝ Hold (C)
11/6/2026	CVS CVS Health	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$103.00
11/5/2026	CVS CVS Health	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$118.00 ➝ $107.00
11/5/2026	CVS CVS Health	Leerink Partners Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Outperform	$112.00 ➝ $104.00
11/5/2026	CVS CVS Health	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Overweight	$108.00 ➝ $107.00
11/4/2026	CVS CVS Health	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$103.00
11/4/2026	CVS CVS Health	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Outperform	$120.00
11/4/2026	CVS CVS Health	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$110.00
11/4/2026	CVS CVS Health	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy
11/4/2026	CVS CVS Health	Evercore Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Outperform

(Data available from 11/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVS CVS Health	$402.07B	0.28	$14.96 per share	5.98	$63.06 per share	1.42
DB Deutsche Bank	$33.22B	2.18	$5.22 per share	7.15	$47.99 per share	0.78
LEA Lear	$23.79B	0.22	$26.12 per share	4.20	$106.69 per share	1.03
MS Morgan Stanley	$74.84B	3.98	$13.76 per share	13.85	$69.46 per share	2.74
POST Post	$8.16B	0.45	$18.32 per share	4.41	$69.29 per share	1.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVS CVS Health	$1.77B	$8.59	10.69	10.35	0.77	2.62%	13.65%	4.20%	N/A
DB Deutsche Bank	$7.47B	$3.86	9.67	8.35	0.58	11.59%	8.63%	0.48%	1/28/2027 (Estimated)
LEA Lear	$436.80M	$11.45	9.58	6.50	0.62	2.46%	14.92%	5.10%	N/A
MS Morgan Stanley	$16.86B	$12.60	15.13	14.29	1.25	15.63%	19.26%	1.28%	1/14/2027 (Estimated)
POST Post	$335.70M	$5.44	14.85	12.33	N/A	3.48%	13.22%	3.42%	11/19/2026 (Estimated)

Latest CVS, DB, LEA, MS, and POST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/19/2026	Q4 2026	POST Post	$1.78	N/A	N/A	N/A	$2.00 billion	N/A
11/4/2026	Q3 2026 & Investor update	CVS CVS Health	$1.65	$2.09	+$0.44	$1.68	$104.72 billion	$108.40 billion
10/30/2026	Q3 2026	LEA Lear	$3.32	$3.71	+$0.39	$2.74	$5.81 billion	$5.77 billion
10/28/2026	Q3 2026 Pre Recorded	DB Deutsche Bank	$0.9140	$1.06	+$0.1460	$1.06	$9.32 billion	$9.44 billion
10/14/2026	Q3 2026	MS Morgan Stanley	$2.93	$3.03	+$0.10	$3.03	$19.93 billion	$20.34 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVS CVS Health	$2.66	2.97%	+5.87%	30.97%	4 Years
DB Deutsche Bank	$0.21	0.57%	N/A	5.47%	4 Years
LEA Lear	$3.08	2.81%	+24.74%	26.90%	N/A
MS Morgan Stanley	$4.60	2.41%	+22.42%	36.51%	12 Years
POST Post	N/A	N/A	N/A	N/A	N/A

Latest CVS, DB, LEA, MS, and POST Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
10/14/2026	MS Morgan Stanley	quarterly	$1.15	2.49%	10/30/2026	10/30/2026	11/13/2026
9/30/2026	CVS CVS Health	quarterly	$0.6650	2.81%	10/22/2026	10/22/2026	11/2/2026
8/13/2026	LEA Lear	quarterly	$0.77	2.37%	9/2/2026	9/2/2026	9/22/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVS CVS Health	0.71	0.85	0.66
DB Deutsche Bank	1.35	0.72	0.72
LEA Lear	0.40	1.18	0.92
MS Morgan Stanley	3.58	0.79	0.79
POST Post	2.47	1.85	0.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVS CVS Health	80.66%
DB Deutsche Bank	27.90%
LEA Lear	97.04%
MS Morgan Stanley	84.19%
POST Post	94.85%

Insider Ownership

Company	Insider Ownership
CVS CVS Health	0.85%
DB Deutsche Bank	N/A
LEA Lear	1.02%
MS Morgan Stanley	0.17%
POST Post	14.05%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVS CVS Health	300,000	1.28 billion	1.27 billion	Optionable
DB Deutsche Bank	89,879	1.94 billion	N/A	Optionable
LEA Lear	164,300	48.19 million	47.70 million	Optionable
MS Morgan Stanley	82,992	1.56 billion	1.56 billion	Optionable
POST Post	13,180	45.32 million	38.96 million	Optionable

CVS, DB, LEA, MS, and POST Headlines

Recent News About These Companies

Post (POST) Expected to Release Quarterly Earnings on Thursday

1 minutes ago | americanbankingnews.com

Post (POST) Projected to Post Quarterly Earnings on Thursday

2 minutes ago | marketbeat.com

Daishinku Reports First-Half Results, Posts Net Loss

17 minutes ago | tipranks.com

GMO Financial Gate Posts Higher Fiscal 2026 Non-Consolidated Results

17 minutes ago | tipranks.com

Tokyo Kisen Posts September 2026 Consolidated Results

1 hour ago | tipranks.com

A Wild Week: Post-Election Sector Rankings

1 hour ago | seekingalpha.com

Paysign's Post-Q3 Selloff Opens An Opportunity

2 hours ago | seekingalpha.com

How Trump maneuvered to the brink of building his 250-foot triumphal arch - The Washington Post

4 hours ago | news.google.comN

American Financial Earnings Call Highlights Record Growth

November 11 at 7:31 PM | tipranks.com

Pete Hegseth and others reprimanded by guard at the Tomb of the Unknown Soldier - NBC News

November 11 at 5:11 PM | news.google.comN

Lakefront Reports Nine-Month Results, Gamgertamig ASH Poster Accepted

November 11 at 4:50 PM | tipranks.com

Armada Gida Says Social-Media Posts About Shares Are False

November 11 at 1:31 PM | tipranks.com

Can Post Holdings' Foodservice Benefit From Normalized Egg Pricing?

November 11 at 1:31 PM | zacks.com

White House Threatens Congress, Saying Aggressive Investigations Could Be Crime - The New York Times

November 11 at 1:10 PM | news.google.comN

Crude Oil Gains 2%; CoreWeave Posts Upbeat Q3 Results

November 11 at 12:31 PM | benzinga.com

White House threatens criminal investigation into Democrats’ oversight efforts - Politico

November 11 at 12:30 PM | news.google.comN

USA Rare Earth Jumps 11% as It Rebounds From Post-Earnings Sell-Off; MP Materials Climbs 4%, United States Antimony Edges Higher

November 11 at 12:11 PM | 247wallst.com

On Holding Posts Slight Q3 Beat, Analysts Expect Growth To Accelerate In Q4

November 11 at 11:51 AM | benzinga.com

Shanghai HeartCare Sets Postponed EGM for November 26, 2026

November 11 at 9:51 AM | tipranks.com

CoreWeave, Inc. (CRWV) Stock: Rebounds 14.63% in Premarket as New AI Database Launches

November 11 at 9:31 AM | blockonomi.com

RKLB Stock Price Forecast: How Much Upside Do Analysts See Post-Q3 Earnings?

November 11 at 8:51 AM | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CVS, DB, LEA, MS, and POST Company Descriptions

CVS Health NYSE:CVS

$89.43 +0.42 (+0.47%)

Closing price 11/11/2026 03:59 PM Eastern

Extended Trading

$89.64 +0.20 (+0.23%)

As of 11/11/2026 07:59 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Deutsche Bank NYSE:DB

$37.32 +0.22 (+0.58%)

Closing price 11/11/2026 03:59 PM Eastern

Extended Trading

$37.28 -0.03 (-0.09%)

As of 11/11/2026 07:49 PM Eastern

Deutsche Bank Aktiengesellschaft, a stock corporation, provides corporate and investment banking, and asset management products and services to private individuals, corporate entities, and institutional clients in Germany, the United Kingdom, rest of Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through Corporate Bank, Investment Bank, Private Bank, and Asset Management segments. The Corporate Bank segment offers cash management, trade finance and lending, trust and agency, and securities services, as well as risk management solutions. The Investment Bank segment provides debt origination, merger and acquisitions, foreign exchange, and equity advisory and origination platform services. The Private Bank segment offers payment and account services, and credit and deposit products, as well as investment advice products, such as environmental, social, and governance products. This segment also provides banking, wealth management, other financial, and postal and parcel services; and supports in planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The Asset Management segment offers investment solutions, such as alternative investments, which include real estate, infrastructure, liquid real assets, and sustainable investments; and various other services, including insurance and pension solutions, asset liability management, portfolio management solutions, and asset allocation advisory to individuals and institutions. Deutsche Bank Aktiengesellschaft was founded in 1870 and is headquartered in Frankfurt am Main, Germany.

Lear NYSE:LEA

$109.71 +0.11 (+0.10%)

Closing price 11/11/2026 03:59 PM Eastern

Extended Trading

$113.75 +4.04 (+3.69%)

As of 11/11/2026 07:55 PM Eastern

Lear Corporation designs, develops, engineers, manufactures, assembles, and supplies automotive seating, and electrical distribution systems and related components for automotive original equipment manufacturers in North America, Europe, Africa, Asia, and South America. Its Seating segment offers seat systems, seat subsystems, keyseat components, seat trim covers, seat mechanisms, seat foams, and headrests, as well as surface materials, such as leather and fabric for automobiles and light trucks, compact cars, pick-up trucks, and sport utility vehicles. The company's E-Systems segment provides electrical distribution and connection systems that route electrical signals and networks; and manage electrical power within the vehicle for various powertrains. This segment's products comprise wire harnesses, terminals and connectors, engineered components, and junction boxes; electronic system products, including body domain control modules, smart and passive junction boxes, gateway and communication modules, integrated power modules, and high voltage switching and power control systems. It also offers software and connected services comprising Xevo Market, an in-vehicle commerce and service platform; and software and services for the cloud, vehicles, and mobile devices. In addition, this segment provides cybersecurity software; advanced vehicle positioning for automated and autonomous driving applications; and short-range communication and cellular protocols for vehicle connectivity. It offers its products and services under the XEVO, GUILFORD, EAGLE OTTAWA, ConfigurE+, INTUTM, LEAR CONNEXUSTM, EXO, JOURNEYWARE, ProTec, SMART JUNCTION BOX, STRUCSURE, AVENTINO, and TeXstyle brands. Lear Corporation was founded in 1917 and is headquartered in Southfield, Michigan.

Morgan Stanley NYSE:MS

$190.59 +3.03 (+1.62%)

Closing price 11/11/2026 03:59 PM Eastern

Extended Trading

$190.64 +0.05 (+0.03%)

As of 11/11/2026 08:00 PM Eastern

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.

Post NYSE:POST

$80.77 -1.06 (-1.30%)

Closing price 11/11/2026 03:59 PM Eastern

Extended Trading

$79.42 -1.35 (-1.68%)

As of 11/11/2026 07:55 PM Eastern

Post Holdings, Inc. operates as a consumer packaged goods holding company in the United States and internationally. It operates through four segments: Post Consumer Brands, Weetabix, Foodservice, and Refrigerated Retail. The Post Consumer Brands segment manufactures, markets, and sells branded and private label ready-to-eat (RTE) cereals under Honey Bunches of Oats, Pebbles, and Malt-O-Meal brand names; hot cereal; peanut butter under the Peter Pan brand; and branded and private label dog and cat food products under Rachael Ray Nutrish, Nature's Recipe, 9Lives, Kibbles 'n Bits and Gravy Train brand names. The Weetabix segment primarily manufactures, markets, and distributes branded and private label RTE cereal under Weetabix and Alpen brands; hot cereals and other cereal-based food products; breakfast drinks; protein-based shakes under the UFIT brand, and nutritional snacks, such as muesli. The Foodservice segment produces and distributes egg products primarily under Papetti's and Abbotsford Farms brands, as well as potato products in the foodservice and food ingredient channels. The segment also manufactures certain meat products. The Refrigerated Retail segment produces and distributes side dish, potato, sausage products under Bob Evans, Bob Evans Farms, and Simply Potatoes brands; eggs and egg products under Bob Evans Egg Whites and Egg Beaters brands; and cheese, and other dairy and refrigerated products under Crystal Farms brand. It serves grocery stores, mass merchandise customers, supercenters, club stores, natural/specialty stores, dollar stores, discounters, wholesalers, convenience stores, pet supply retailers, drug store customers, foodservice distributors, and national restaurant chains, as well as sells its products in the military, ecommerce, and foodservice channels. The company was founded in 1895 and is headquartered in Saint Louis, Missouri.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CVS, DB, LEA, MS, and POST Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CVS, DB, LEA, MS, and POST Earnings

Compare Dividends

Latest CVS, DB, LEA, MS, and POST Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CVS, DB, LEA, MS, and POST Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CVS, DB, LEA, MS, and POST Company Descriptions

CVS Health NYSE:CVS

Deutsche Bank NYSE:DB

Lear NYSE:LEA

Morgan Stanley NYSE:MS

Post NYSE:POST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools